-
CME Information or Content Source:This activity will be CME/CPE/CNE-certified.
-
Event Sponsor(s):This activity is supported by an educational grant from Bristol Myers Squibb.
-
Event Details:Program provided by Boston University (BU) and Association of Community Cancer Centers (ACCC).
-
Expires:May 16, 2023
Course Description
Could you benefit from expert advice on the optimal management of Immune-related Adverse Events (irAE)? If so, please join the Association of Community Cancer Centers and Boston University on the third Tuesday of every month from 3:00 – 4:00 PM ET for complimentary telementoring sessions. Each month we will cover a different topic, allowing you to receive guidance on clinical cases and have your questions answered by expert faculty. Registration is free and you will automatically be signed up for all sessions.
Learning Objectives
At the end of this educational activity, participants will be able to:
- Apply evidence-based practices for the monitoring and management of irAE in patients receiving cancer immunotherapies
- Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAE in patients receiving cancer immunotherapies
- Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies
We welcome you to submit unidentified clinical case scenarios for each of the tumor-board style discussions. Submission instructions will be available upon registration.
Target Audience
Oncologists, Nurses, Nurse Practitioners, Physician Assistants, Pharmacists, and other healthcare professionals involved in treating patients with cancer immunotherapies.
